Skip to main content

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings

Shares (Q2 2026)
14
Value
$660
% of portfolio
<0.1%
Quarters held
7
Since Q2 2021
Holdings of DFTX by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614$660<0.1%+14NewHolders
Q4 20220$00.0%−10−100.0%Sold outHolders
Q3 202210$00.0%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 2022150$00.0%−4,255−96.6%ReducedHolders
Q1 20224,405$5.00K<0.1%00.0%UnchangedHolders
Q4 20214,405$6.00K<0.1%+1,255+39.8%AddedHolders
Q3 20213,150$8.00K<0.1%+150+5.0%AddedHolders
Q2 20213,000$10.0K<0.1%+3,000NewHolders